CD38 and head and neck squamous cell carcinoma: Moreover, our previous study [53] showed that CD38 deletion upregulates TLR4 expression, and also, there is a paper [54] reporting that CD38 can induce inflammasome-mediated activation of caspase-1 by activating NLRP3 in head and neck squamous cell carcinoma (HNSCC).